Sunesis Pharmaceuticals (SNSS) 2.57 $SNSS Biotech Stock

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 10:24 PM

Sunesis Pharmaceuticals (SNSS) 2.57 $SNSS

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
at The Street - Fri Apr 10, 5:01AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care.
BIIB: 423.57 (+1.46), SNSS: 2.57 (-0.11), RCPT: 166.76 (-3.37), MNKD: 4.90 (-0.09), CELG: 115.54 (+0.72)

Sunesis Pharmaceuticals (SNSS) Strong On High Relative Volume Today
at The Street - Wed Apr 08, 9:02AM CDT
Trade-Ideas LLC identified Sunesis Pharmaceuticals (SNSS) as a strong on high relative volume candidate
SNSS: 2.57 (-0.11)

Sunesis Pharmaceuticals Inc.'s CEO Daniel Swisher Interviewed by The Life Sciences Report
Marketwired - Thu Apr 02, 1:34PM CDT
Cancers are among today's most significant unmet medical needs. Take, for example, acute myelogenous leukemia: No new therapeutics have hit the marketplace in more than forty years. In this interview with The Life Sciences Report, Daniel N. Swisher Jr., president and CEO of Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), describes how his company is making clinical progress toward developing a new treatment for this devastating disease, and how the broad Sunesis kinase inhibitor portfolio provides additional firepower against other cancers. With a number of share-moving catalysts on the horizon, Sunesis expects to hit the mark both for patients and investors.
SNSS: 2.57 (-0.11)

Morning Briefing on Biotech Equities -- OPKO Health, Progenics Pharma, Neuralstem, Nanosphere, and Sunesis Pharma
PR Newswire - Tue Mar 31, 8:05AM CDT
Editor Note: For more information about this release, please scroll to bottom.
PGNX: 6.33 (-0.12), OPK: 14.60 (+0.17), SNSS: 2.57 (-0.11), NSPH: 4.05 (+0.10), CUR: 1.96 (-0.04)

4 Biotech Stocks Under $10 to Trade for Breakouts
at The Street - Tue Mar 24, 1:13PM CDT
These under-$10 biotech stocks are within range of triggering breakout trades.
ECYT: 6.37 (unch), SNSS: 2.57 (-0.11), BCLI: 4.29 (-0.09), XOMA: 3.63 (-0.04)

Sunesis Pharmaceuticals (SNSS) Weak On High Volume
at The Street - Fri Mar 20, 9:14AM CDT
Trade-Ideas LLC identified Sunesis Pharmaceuticals (SNSS) as a weak on high relative volume candidate
SNSS: 2.57 (-0.11)

Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 12, 1:23PM CDT

SNSS: 2.57 (-0.11)

Sunesis Pharmaceuticals (SNSS) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Mar 12, 9:55AM CDT

SNSS: 2.57 (-0.11)

Sunesis Pharma net loss improves in Q4
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 9:10AM CDT

SNSS: 2.57 (-0.11)

Sunesis Pharmaceuticals beats by $0.18, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 7:56AM CDT

SNSS: 2.57 (-0.11)

Sunesis reports 4Q loss
Automated Insights - Thu Mar 12, 6:27AM CDT
SOUTH SAN FRANCISCO, Calif. (AP) _ Sunesis Pharmaceuticals Inc. (SNSS) on Thursday reported a loss of $1.3 million in its fourth quarter.
SNSS: 2.57 (-0.11)

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2014 Financial Results and Recent Highlights
GlobeNewswire - Thu Mar 12, 6:00AM CDT
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the fourth quarter and year ended December 31, 2014. Loss from operations for the three months and year ended December 31, 2014 was $11.2 million and $45.0 million, respectively. As of December 31, 2014, cash, cash equivalents and marketable securities totaled $43.0 million.
SNSS: 2.57 (-0.11)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 4:30PM CDT

CRME: 9.97 (-0.11), JASO: 10.36 (+0.36), QIWI: 25.82 (+0.68), PGEM: 14.26 (+0.15), KIRK: 23.48 (+0.13), TLP: 35.99 (+0.46), CVGW: 49.75 (-1.26), GCO: 70.47 (+1.27), CSTM: 18.15 (+0.08), CMN: 48.33 (+0.23), HOV: 3.36 (-0.08), RICE: 22.63 (+0.33), PWE: 2.38 (+0.03), GLP: 40.11 (+0.96), BONT: 7.05 (-0.17), PLCE: 62.17 (-0.18), SNSS: 2.57 (-0.11), LEAF: 51.70 (-0.34), DG: 75.83 (-0.18), MTN: 104.71 (+0.18), SMRT: 12.01 (+0.12)

Sunesis Announces Amendment to Loan Agreement
GlobeNewswire - Mon Mar 02, 6:00AM CST
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced the signing of an amendment to its loan and security agreement (the "Loan Agreement"

with Oxford Finance LLC, Silicon Valley Bank, and Horizon Technology Finance Corporation (collectively, "the Lenders"

.
SNSS: 2.57 (-0.11)

4 Health Care Stocks Under $10 to Watch: ImmunoGen, Bacterin and More
at The Street - Thu Feb 19, 12:23PM CST
Keep these under-$10 health care stocks on your trading radar.
PHMD: 1.96 (+0.02), IMGN: 9.96 (+0.01), SNSS: 2.57 (-0.11)

Expert Briefing on Biotech Stocks - Lexicon Pharma, Sunesis Pharma, Navidea Biopharma, Tekmira Pharma, and Intrexon
PR Newswire - Thu Feb 19, 7:35AM CST
Editor Note: For more information about this release, please scroll to bottom.
NAVB: 1.50 (unch), LXRX: 1.06 (-0.01), XON: 44.53 (+0.36), TKMR: 18.38 (-0.14), SNSS: 2.57 (-0.11)

Sunesis to Present at the 2015 RBC Capital Markets' Global Healthcare Conference
GlobeNewswire - Wed Feb 18, 6:06AM CST
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Eric Bjerkholt, Executive Vice President of Corporate Development and Finance and Chief Financial Officer of Sunesis, will present at the 2015 RBC Capital Markets' Global Healthcare Conference on Wednesday, February 25 at 11:30 AM Eastern Time at the New York Palace Hotel in New York City.
SNSS: 2.57 (-0.11)

The Life Sciences Report Releases 2015 Small-Cap Biotech Watchlist Panel Comments
Marketwired - Tue Feb 03, 8:15AM CST
Streetwise Reports/The Life Sciences Report released notes from the 2015 Small-Cap Biotech Watchlist panel discussion, which occurred at the Biotech Showcase in San Francisco on January 13. The Watchlist companies selected by top sector analysts include Can-Fite BioPharma Ltd. (NYSE MKT: CANF) and Sunesis Pharmaceuticals (NASDAQ: SNSS). The panel focused on companies they believe should see significant gains in 2015.
CANF: 2.12 (+0.17), SNSS: 2.57 (-0.11)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 8:07AM CST

SID: 2.13 (+0.16), FRO: 2.77 (-0.20), GGB: 3.28 (+0.20), NERV: 5.68 (+0.05), CYTR: 5.21 (-0.06), SNSS: 2.57 (-0.11), NQ: 4.16 (+0.04), XOOM: 15.95 (+0.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hyundai Teases 2027 TUCSON: Global Reveal Imminent

Hyundai Sets the Stage for the 2027 TUCSON Hyundai’s ready to roll out its shiny new set of wheels, the 2027 TUCSON, and boy, they sure know how to make an entrance. Mark your calendars for October 1—it's happening right in the Big Apple, none other than Long Island City. Expect the spotlight to hit at precisely 5:15 p.m. ET, and don't worry if you can't snag a...

Alito's Recusal: Supreme Court Climate Case Shaker

Justice Alito Bows Out from A High-Stakes Climate Battle September 28, 2026, marked a notable turn in the legal landscape. Supreme Court Justice Samuel Alito chose to step away from a case that's got every investor, lawyer, and policy wonk on the edge of their seats—Suncor v. Boulder. This isn't about just any old courtroom squabble; it's a landmark climate case poised...

BLM's Wild Horse Strategy: Fertility Control's Time to Shine

Wild Horse Management Gets a Shot in the Arm Amigo, when the federal government throws $30 million dollars at a problem, you'd hope they're not just throwing us a bone. The Bureau of Land Management (BLM) now has this hefty sum courtesy of the U.S. Department of Agriculture, intended to expand wild horse fertility control across the sprawling landscapes they roam. This...

Beasley and Vegas Golden Knights Partner for Broadcast

Strategic Moves on the Airwaves The Vegas Golden Knights are skating into a new era of broadcasting. Teaming up with Beasley Media Group, they've inked a multiyear deal that makes the media outfit their official audio partner. Dropping the puck on this relationship means folks in Southern Nevada can catch the action on Beasley's English and Spanish stations. It's a hefty...

Multiply's AI Agent Tackles $126K Google Ads Waste

AI Steps In Where Marketers Hit a Wall Picture this: marketers drowning in search terms flying at them faster than they can blink. Multiply's new AI-powered Ad Spend Recovery Agent steps in, claiming to save an eye-watering $126,000 per year by cutting Google Ads waste. Talk about having a hawk-eyed auditor sifting through your accounts. Shaking Up Traditional Automation...

Colson Group Expands with Algood Acquisition

A Big Move in Mobility Solutions Put on your seatbelts, because Colson Group is steering into a new lane with its acquisition of Algood Caster Innovations. This ain't just any pickup—it's a smart move that could ramp up their North American manufacturing clout and mobility solutions. You know, mergers like these don't come around by accident. Colson sees something...

Janitorial Wages Soar 26.7% Amid High Annual Openings

Janitorial Sector Faces Wage Surge and Employment Shifts Look, if you thought the world of janitorial work was all brooms and mops without a paycheck edge, think again. From 2020 to 2025, wages for janitors and building cleaners didn't just tip-toe up the ladder—they practically sprinted, climbing 26.7%. BLS data laid this one out, with hourly pay shooting from $13.98...

Kansas Marijuana DUI Laws: What Drivers Must Know

Navigating the Legal Maze of Marijuana DUIs Marijuana DUI, ever heard of it? Many folks in Kansas might just find themselves scratching their heads. While booze clearly shouts 'DUI' when you hit the road sauced, the green stuff doesn’t dodge that same bullet. You better believe it, Kansas doesn’t mess around when it comes to drugs behind the wheel, and marijuana is...

Claigan Webinar Tackles Prop 65 Warnings for 2028

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

SOA Elects New Leaders for 2026: A Look Ahead

A New Lineup for SOA's Board in 2026 On the financial frontlines, few organizations hold the clout that the Society of Actuaries (SOA) wields. With their latest round of elections completed, they've named five fresh Board members along with both a new President Elect and Vice Chair for the upcoming 2026-2027 term. These folks are gearing up to take the stage right after...